Emergency contraception

Overview Of Emergency contraception

Pneumocystis jiroveci pneumonia (PJP) is a severe lung infection caused by the fungus *Pneumocystis jiroveci*, commonly affecting immunocompromised individuals. It leads to inflammation and fluid accumulation in the lungs, causing difficulty in breathing and low oxygen levels.

Causes of Emergency contraception

• PJP is caused by *Pneumocystis jiroveci*, a fungus typically found in healthy individuals without causing illness. In those with weakened immune systems, such as HIV/AIDS patients or those on immunosuppressive therapy, the fungus can become pathogenic. It is believed to spread through respiratory droplets.

Risk Factors of Emergency contraception

• Individuals with HIV/AIDS, organ transplant recipients, cancer patients, and those on immunosuppressive drugs are at high risk of developing PJP.

Prevention of Emergency contraception

• Prevention involves prophylactic antibiotics for high-risk individuals, particularly those with HIV/AIDS or organ transplants, to reduce the risk of developing PJP.

Prognosis of Emergency contraception

• With prompt treatment, the prognosis for PJP has improved, though it remains serious in immunocompromised individuals. Early detection is crucial for a better outcome.

Complications of Emergency contraception

• Complications of PJP include respiratory failure, pneumothorax, acute respiratory distress syndrome (ARDS), and secondary infections.

Related Diseases of Emergency contraception

• Conditions that can be related to PJP include fungal infections like Aspergillus and other lung diseases such as tuberculosis or viral pneumonia.

Treatment of Emergency contraception

First-line treatment is trimethoprim-sulfamethoxazole (TMP-SMX). Alternatives include pentamidine, atovaquone, and dapsone. In severe cases, corticosteroids may be used to reduce inflammation.